充血性心力衰竭 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

SPECT and PET in ischemic heart failure
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction
Modifiable lifestyle factors and heart failure: A Mendelian randomization study
Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
Heart Failure and Atrial Fibrillation, Like Fire and Fury
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure
Dilated cardiomyopathy: so many cardiomyopathies!
Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry

Original Research

2018;7:e009806

JOURNAL：JAHA

Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries

Ki Hong Choi Jin‐Oh Choi et al.

4677

Keywords: heart failure with midrange ejection fraction; HFmrEF; acute HF; β‐blocker; renin‐angiotensin system blocker; all‐cause mortality

FULL TEXT PDF